IMMUNITYBIO, INC. Variable Lease, Cost
IMMUNITYBIO, INC. (IBRX) reported Variable Lease, Cost of $920.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-05-07
- IMMUNITYBIO, INC. variable lease, cost for the quarter ending 2026-03-31 was $920.00K, a 13.58% increase year-over-year.
- IMMUNITYBIO, INC. variable lease, cost for the quarter ending 2025-12-31 was $952.00K, a 10.61% decline year-over-year.
- IMMUNITYBIO, INC. variable lease, cost for the quarter ending 2025-09-30 was $762.00K, a 21.36% decline year-over-year.
- IMMUNITYBIO, INC. variable lease, cost for the quarter ending 2025-06-30 was $960.00K, a 3.71% decline year-over-year.
- IMMUNITYBIO, INC. variable lease, cost for fiscal 2025 was $3.48M, a 11.73% decline from fiscal 2024.
- IMMUNITYBIO, INC. variable lease, cost for fiscal 2024 was $3.95M, a 12.10% increase from fiscal 2023.
- IMMUNITYBIO, INC. variable lease, cost for fiscal 2023 was $3.52M, a 9.25% decline from fiscal 2022.
- IMMUNITYBIO, INC. variable lease, cost for fiscal 2022 was $3.88M, a 35.57% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $920.00K 10-Q · filed 2026-05-07 | $1.87M derived: sum of 2 quarters · filed 2026-05-07 | $2.63M derived: sum of 3 quarters · filed 2026-05-07 | $3.59M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-12-31 | $952.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.71M derived: sum of 2 quarters · filed 2026-02-23 | $2.67M derived: sum of 3 quarters · filed 2026-02-23 | $3.48M 10-K · filed 2026-02-23 | |
| 2025-09-30 | $762.00K 10-Q · filed 2025-11-05 | $1.72M derived: sum of 2 quarters · filed 2025-11-05 | $2.53M 10-Q · filed 2025-11-05 | $3.60M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-06-30 | $960.00K 10-Q · filed 2025-08-05 | $1.77M 10-Q · filed 2025-08-05 | $2.83M derived: sum of 3 quarters · filed 2026-05-07 | $3.80M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-03-31 | $810.00K 10-Q · filed 2026-05-07 | $1.88M derived: sum of 2 quarters · filed 2026-05-07 | $2.84M derived: sum of 3 quarters · filed 2026-05-07 | $3.84M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $2.03M derived: sum of 2 quarters · filed 2026-02-23 | $3.03M derived: sum of 3 quarters · filed 2026-02-23 | $3.95M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $969.00K 10-Q · filed 2025-11-05 | $1.97M derived: sum of 2 quarters · filed 2025-11-05 | $2.88M 10-Q · filed 2025-11-05 | $3.48M derived: sum of 4 quarters · filed 2026-02-23 | |
| 2024-06-30 | $997.00K 10-Q · filed 2025-08-05 | $1.91M 10-Q · filed 2025-08-05 | $2.51M derived: sum of 3 quarters · filed 2026-02-23 | $3.49M derived: sum of 4 quarters · filed 2026-02-23 | |
| 2024-03-31 | $916.00K 10-Q · filed 2025-05-12 | $1.51M derived: sum of 2 quarters · filed 2026-02-23 | $2.49M derived: sum of 3 quarters · filed 2026-02-23 | $3.47M derived: sum of 4 quarters · filed 2026-02-23 | |
| 2023-12-31 | $599.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $1.58M derived: sum of 2 quarters · filed 2026-02-23 | $2.55M derived: sum of 3 quarters · filed 2026-02-23 | $3.52M 10-K · filed 2026-02-23 | |
| 2023-09-30 | $977.00K 10-Q · filed 2024-11-12 | $1.95M derived: sum of 2 quarters · filed 2024-11-12 | $2.92M 10-Q · filed 2024-11-12 | $3.88M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $975.00K 10-Q · filed 2024-08-12 | $1.95M 10-Q · filed 2024-08-12 | $2.90M derived: sum of 3 quarters · filed 2025-03-03 | $3.71M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $970.00K 10-Q · filed 2024-05-09 | $1.93M derived: sum of 2 quarters · filed 2025-03-03 | $2.73M derived: sum of 3 quarters · filed 2025-03-03 | $3.67M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $956.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $1.76M derived: sum of 2 quarters · filed 2025-03-03 | $2.70M derived: sum of 3 quarters · filed 2025-03-03 | $3.88M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $808.00K 10-Q · filed 2023-11-09 | $1.74M derived: sum of 2 quarters · filed 2023-11-09 | $2.92M 10-Q · filed 2023-11-09 | $3.75M derived: sum of 4 quarters · filed 2024-03-19 | |
| 2022-06-30 | $934.00K 10-Q · filed 2023-08-08 | $2.12M 10-Q · filed 2023-08-08 | $2.94M derived: sum of 3 quarters · filed 2024-03-19 | $3.79M derived: sum of 4 quarters · filed 2024-03-19 | |
| 2022-03-31 | $1.18M 10-Q · filed 2023-05-11 | $2.00M derived: sum of 2 quarters · filed 2024-03-19 | $2.86M derived: sum of 3 quarters · filed 2024-03-19 | $3.38M derived: sum of 4 quarters · filed 2024-03-19 | |
| 2021-12-31 | $823.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $1.68M derived: sum of 2 quarters · filed 2024-03-19 | $2.20M derived: sum of 3 quarters · filed 2024-03-19 | $2.86M 10-K · filed 2024-03-19 | |
| 2021-09-30 | $856.00K 10-Q · filed 2022-11-09 | $1.37M derived: sum of 2 quarters · filed 2022-11-09 | $2.04M 10-Q · filed 2022-11-09 | $3.12M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $517.00K 10-Q · filed 2022-08-08 | $1.18M 10-Q · filed 2022-08-08 | $2.26M derived: sum of 3 quarters · filed 2023-03-01 | $3.17M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $666.00K 10-Q · filed 2022-05-10 | $1.75M derived: sum of 2 quarters · filed 2023-03-01 | $2.66M derived: sum of 3 quarters · filed 2023-03-01 | $3.38M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.99M derived: sum of 2 quarters · filed 2023-03-01 | $2.72M derived: sum of 3 quarters · filed 2023-03-01 | $3.56M 10-K · filed 2023-03-01 | $1.57M 10-K · filed 2021-03-04 |
| 2020-09-30 | $909.00K 10-Q · filed 2021-11-12 | $1.64M derived: sum of 2 quarters · filed 2021-11-12 | $2.48M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $726.00K 10-Q · filed 2021-08-12 | $1.57M 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $848.00K 10-Q · filed 2021-05-14 | ||||
| 2019-12-31 | $2.76M 10-K · filed 2022-03-01 | $1.22M 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |